IP Library Granted Patent US 11,547,316
Granted Patent B2
US 11,547,316 · App. 17/866,171 · Granted Jan 10, 2023

Apparatus and method for treatment of pain with body impedance analyzer

Inventors: John Crosson (Pacific Palisades, CA); David Weinkle (Cypress, CA)
Assignee: TrueRelief, LLC
A61B5/0531A61B5/053A61B5/4824A61B5/742A61B5/7475A61H39/002A61N1/3603A61N1/36021A61H2201/501A61H2201/5046A61H2201/5048A61H2230/655
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,547,316
App. No.
17/866,171
Granted
Jan 10, 2023
Kind
B2
Abstract

A patient treatment unit and method analyzes and treats pain in tissues by applying an electrical pulse train to the affected tissue. The impedance of the affected tissue is measured, and the measured impedance is correlated to a level of pain in the patient. The pulse train is further applied in response to the measured impedance to reduce the patient's pain. The patient treatment unit includes a probe stimulus generator that outputs the pulse train. The treatment unit also includes a pair of probes for contacting the patient's body and receiving the pulse train. The pulse has improved shaping based on isolation of high voltage from a low voltage control. The unit further includes a body impedance analysis circuit that senses voltage and current via the probes when the probes are contacting the patient and observe the impedance. A monitor is electrically coupled to the body impedance analysis circuit and provides an indication of the measured impedance indicative of the patient's level of pain in real-time.

Claims (23)

1. An apparatus configured to deliver a sequence of electrical pulses to a body during a treatment, the apparatus comprising:

a generator circuit configured to output a sequence of electrical pulses, the electrical pulses having a pulse width and a pulse frequency, a peak pulse amplitude of approximately 190 V, and a maximum output current not exceeding 8.9 mA, the generator circuit controlling the pulse frequency and the pulse width of the electrical pulses,

a first conductor for contacting a first trigger or motor point of a body and electrically coupled to the generator circuit to receive therefrom the sequence of electrical pulses, and a second conductor for contacting a second trigger or motor point of the body and electrically coupled to the generator circuit;

an intensity adjustment circuit configured to adjust an intensity of the electrical pulses in response to intensity inputs;

a plus/minus control;

a display configured to display status information and a timer showing in real time an indication of a duration of time that the electrical pulses have been delivered to the body, the display being further configured to display an indication of the intensity of the electrical pulses being applied to the body; and

a controller configured to end delivery of the electrical pulses to the body in response to pressing an end button;

wherein the pulse frequency of the electrical pulses does not exceed 490 Hz±6% with 500 ohms to 1 mega-ohm of resistance across the first conductor and the second conductor.

2. The apparatus of claim 1 , the display being further configured to display real-time information about the treatment.

3. The apparatus of claim 1 , the display being further configured to display patient-specific data.

4. The apparatus of claim 1 , wherein the indication of the intensity is portrayed on the display as a number value corresponding to a level of intensity.

5. The apparatus of claim 1 , wherein the display is configured to display guided, malady-specific, treatment starting points.

6. The apparatus of claim 1 , wherein the duration of time is an elapsed time since the electrical pulses started being delivered to the body.

7. The apparatus of claim 1 , wherein the first conductor has a spherical tip and the second conductor has a spherical tip.

8. The apparatus of claim 1 , wherein the intensity inputs are provided via an intensity knob or dial.

9. The apparatus of claim 1 , wherein the plus-minus control is provided via a touchscreen.

10. The apparatus of claim 1 , wherein the display includes a touch screen having touch screen controls including the plus-minus control.

11. The apparatus of claim 1 , wherein the first or second trigger or motor point is a nervous system trigger point or a point to provide nerve stimulation, or wherein the first or second trigger or motor point is a wound.

12. The apparatus of claim 1 , wherein the first conductor and the second conductor together constitute a pair of probes that are independently manipulable.

13. The apparatus of claim 1 , used to treat a condition including neuralgia or neuropathy or a disease affecting the body's nervous system.

14. The apparatus of claim 13 , wherein the condition is a pain condition.

15. The apparatus of claim 1 , wherein the first conductor and the second conductor are placed directly against a skin of the body.

16. The apparatus of claim 1 , further comprising a memory storage device to store data about the treatment.

Assignments (4)
SECURITY INTEREST Recorded Jun 5, 2026
From: TRUERELIEF, LLC
To: GLS HOLDINGS, LLC
Reel/Frame 074862/0970 →
SECURITY INTEREST Recorded Apr 21, 2026
From: TRUERELIEF, LLC
To: MEDCAP PARTNERS, LLC
Reel/Frame 074431/0795 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2022
From: CROSSON, JOHN; WEINKLE, DAVID
To: NEWLIFE SCIENCES LLC
Reel/Frame 060675/0109 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2022
From: NEWLIFE SCIENCES LLC
To: TRUERELIEF, LLC
Reel/Frame 060675/0265 →
Continuity (4)
Continuation 16132032 · Sep 14, 2018
Continuation 13990487
Provisional Application 61418111 · Nov 30, 2010
Related Publication 20220346662A1 · Nov 3, 2022
Cited By (4)
US 12,357,824 US 12,453,853 US 12,575,780 US 12,629,522